Valery Radchenko

3.1k total citations
108 papers, 2.1k citations indexed

About

Valery Radchenko is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Valery Radchenko has authored 108 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Radiology, Nuclear Medicine and Imaging, 40 papers in Pulmonary and Respiratory Medicine and 25 papers in Radiation. Recurrent topics in Valery Radchenko's work include Radiopharmaceutical Chemistry and Applications (94 papers), Medical Imaging Techniques and Applications (50 papers) and Medical Imaging and Pathology Studies (24 papers). Valery Radchenko is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (94 papers), Medical Imaging Techniques and Applications (50 papers) and Medical Imaging and Pathology Studies (24 papers). Valery Radchenko collaborates with scholars based in Canada, United States and Russia. Valery Radchenko's co-authors include Paul Schaffer, Caterina F. Ramogida, Andrew K. H. Robertson, Dmitry Filosofov, Elena Kurakina, Justin J. Wilson, Jonathan W. Engle, Hua Yang, Chris Orvig and Kevin D. John and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Valery Radchenko

103 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valery Radchenko Canada	26	1.6k	608	477	389	374	108	2.1k
Aleksander Bilewicz Poland	27	1.1k 0.7×	559 0.9×	370 0.8×	195 0.5×	345 0.9×	102	1.9k
Caterina F. Ramogida Canada	22	1.3k 0.8×	422 0.7×	479 1.0×	189 0.5×	397 1.1×	66	1.7k
Cathy S. Cutler United States	23	1.6k 1.0×	554 0.9×	233 0.5×	235 0.6×	444 1.2×	67	2.5k
M.R.A. Pillai India	29	2.1k 1.3×	942 1.5×	357 0.7×	292 0.8×	350 0.9×	102	2.9k
Eva R. Birnbaum United States	25	825 0.5×	353 0.6×	617 1.3×	327 0.8×	613 1.6×	62	1.8k
Michael E. Fassbender United States	22	956 0.6×	406 0.7×	272 0.6×	426 1.1×	191 0.5×	63	1.4k
Kevin D. John United States	29	783 0.5×	316 0.5×	900 1.9×	277 0.7×	544 1.5×	101	2.3k
Licia Uccelli Italy	26	1.3k 0.8×	621 1.0×	159 0.3×	175 0.4×	135 0.4×	111	1.9k
Atsushi Shinohara Japan	22	516 0.3×	175 0.3×	327 0.7×	259 0.7×	211 0.6×	123	1.6k
F.M. Nortier United States	26	1.2k 0.8×	479 0.8×	271 0.6×	895 2.3×	321 0.9×	84	2.1k

Countries citing papers authored by Valery Radchenko

Since Specialization

Citations

This map shows the geographic impact of Valery Radchenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valery Radchenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valery Radchenko more than expected).

Fields of papers citing papers by Valery Radchenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valery Radchenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valery Radchenko. The network helps show where Valery Radchenko may publish in the future.

Co-authorship network of co-authors of Valery Radchenko

This figure shows the co-authorship network connecting the top 25 collaborators of Valery Radchenko. A scholar is included among the top collaborators of Valery Radchenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valery Radchenko. Valery Radchenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jalilian, Amir Reza, Penelope Bouziotis, Frank Bruchertseifer, et al.. (2025). IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals. Nuclear Medicine and Biology. 144-145. 109008–109008. 2 indexed citations

Maus, Stephan, et al.. (2025). Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+. Nuclear Medicine and Biology. 146-147. 109034–109034. 3 indexed citations

Merkens, Helen, Cristina Rodríguez‐Rodríguez, P. Kunz, et al.. (2024). Preclinical Evaluation of²²⁶Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy. Journal of Nuclear Medicine. 65(11). 1762–1768. 3 indexed citations

Voorde, Michiel Van de, Maarten Ooms, Sathiya Sekar, et al.. (2024). Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development. EJNMMI Physics. 11(1). 77–77. 6 indexed citations

Tosato, Marianna, Mattia Asti, Lars Hemmingsen, et al.. (2024). Capturing Mercury-197m/g for Auger Electron Therapy and Cancer Theranostic with Sulfur-Containing Cyclen-Based Macrocycles. Inorganic Chemistry. 63(30). 14241–14255. 3 indexed citations

Radchenko, Valery, et al.. (2024). Chemistry of Antimony in Radiopharmaceutical Development: Unlocking the Theranostic Potential of Sb Isotopes. ChemPlusChem. 89(12). e202400250–e202400250. 6 indexed citations

Rodríguez‐Rodríguez, Cristina, Pedro L. Esquinas, Helen Merkens, et al.. (2024). First preclinical SPECT/CT imaging and biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617. EJNMMI Radiopharmacy and Chemistry. 9(1). 90–90.

Kunz, P., J. Lassen, C. Andreoiu, et al.. (2023). Understanding radioactive ion beam production at ISAC through yield measurements and simulations. Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms. 541. 117–120. 1 indexed citations

Tosato, Marianna, Yang Gao, Valerio Di Marco, et al.. (2023). Selective Chelation of the Exotic Meitner‐Auger Emitter Mercury‐197 m/g with Sulfur‐Rich Macrocyclic Ligands: Towards the Future of Theranostic Radiopharmaceuticals. Chemistry - A European Journal. 29(21). e202203815–e202203815. 8 indexed citations

10.

Yang, Hua, Marı́a de Guadalupe Jaraquemada-Peláez, Helen Merkens, et al.. (2023). Rearmed Bifunctional Chelating Ligand for ²²⁵Ac/¹⁵⁵Tb Precision-Guided Theranostic Radiopharmaceuticals─H₄noneunpaX. Journal of Medicinal Chemistry. 66(19). 13705–13730. 11 indexed citations

11.

Gates, Byron D., et al.. (2023). Synthesis of ^197m/gHg labelled gold nanoparticles for targeted radionuclide therapy. Radiochimica Acta. 111(10). 773–779. 1 indexed citations

12.

Jaraquemada-Peláez, Marı́a de Guadalupe, Chengcheng Zhang, Jutta Zeisler, et al.. (2022). H₄picoopa─Robust Chelate for ²²⁵Ac/¹¹¹In Theranostics. Bioconjugate Chemistry. 33(10). 1900–1921. 13 indexed citations

13.

Choudhary, Neha, Manja Kubeil, Valery Radchenko, et al.. (2021). Metal ion size profoundly affects H₃glyox chelate chemistry. RSC Advances. 11(26). 15663–15674. 4 indexed citations

14.

Wang, Xiaozhu, Hua Yang, Valery Radchenko, et al.. (2021). High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [¹¹¹In]In³⁺ and [⁸⁹Zr]Zr⁴⁺. Dalton Transactions. 50(11). 3874–3886. 7 indexed citations

15.

Yang, Hua, Justin J. Wilson, Chris Orvig, et al.. (2021). Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review. Journal of Nuclear Medicine. 63(1). 5–13. 58 indexed citations

16.

Choudhary, Neha, Marı́a de Guadalupe Jaraquemada-Peláez, Kristof Zarschler, et al.. (2020). Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions. Inorganic Chemistry. 59(8). 5728–5741. 12 indexed citations

17.

Jaraquemada-Peláez, Marı́a de Guadalupe, Eduardo Aluicio‐Sarduy, Xiaozhu Wang, et al.. (2020). [^nat/44Sc(pypa)]⁻: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. Inorganic Chemistry. 59(3). 1985–1995. 25 indexed citations

18.

Kurakina, Elena, Valery Radchenko, G. A. Bozhikov, et al.. (2020). Perturbed Angular Correlation as a Tool to Study Precursors for Radiopharmaceuticals. Inorganic Chemistry. 59(17). 12209–12217. 7 indexed citations

19.

Rousseau, Julie, Marı́a de Guadalupe Jaraquemada-Peláez, Xiaozhu Wang, et al.. (2020). ²²⁵Ac-H₄py4pa for Targeted Alpha Therapy. Bioconjugate Chemistry. 32(7). 1348–1363. 51 indexed citations

20.

Jaraquemada-Peláez, Marı́a de Guadalupe, Hsiou‐Ting Kuo, Helen Merkens, et al.. (2019). Functionally Versatile and Highly Stable Chelator for ¹¹¹In and ¹⁷⁷Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting. Bioconjugate Chemistry. 30(5). 1539–1553. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact